Anemia and Hematologic Disorders Vocabulary

Overview and Pathophysiology of Anemia

Definition of Anemia:
- Anemia is not a single, specific disease entity, but rather a clinical manifestation of an underlying disorder.
- It is defined as a deficiency in:
  - The total number of circulating erythrocytes (red blood cells [RBCs]).
  - The total quantity of hemoglobin.
  - The volume of packed RBCs (hematocrit).
Physiological Function of Red Blood Cells:
- Transport oxygen ( $\text{O}_2$ ) from the lungs to systemic body tissues.
- Carry carbon dioxide ( $\text{CO}_2$ ) from systemic tissues back to the lungs.
Erythrocyte Production Dynamics:
- Normal operational lifespan of a mature RBC is $120\,\text{days}$ .
- Three primary alterations in erythropoiesis lead to decreased RBC production:
  - Decreased hemoglobin synthesis.
  - Defective DNA synthesis within RBCs.
  - Diminished availability of erythrocyte precursors.
Etiological Classification of Anemia:
- Decreased RBC Production:
  - Deficient Nutrients: Iron deficiency, Cobalamin (Vitamin $\text{B}_{12}$ ) deficiency, Folic acid deficiency.
  - Decreased Erythropoietin: Reduced renal production of erythropoietin.
  - Decreased Iron Availability: Impaired iron release from storage sites.
- Blood Loss:
  - Chronic Hemorrhage: Bleeding duodenal ulcer, colorectal cancer, liver disease.
  - Acute Blood Loss: Acute trauma, ruptured aortic aneurysm, gastrointestinal (GI) bleeding.
- Increased RBC Destruction (Hemolysis):
  - Intrinsic Factors: Sickle cell disease.
  - Medications: Methyldopa (Aldomet).
  - Immune Destruction: Incompatible blood transfusions.
  - Physical / Mechanical Trauma: Cardiopulmonary bypass procedures.

Diagnostic Evaluation and Clinical Manifestations

Classification Methods:
- Morphologic Classification:
  - Based on cellular characteristics (size, shape, color).
  - Provides descriptive, objective laboratory data.
  - Evaluated via complete blood count (CBC), reticulocyte count, and peripheral blood smear.
- Etiologic Classification:
  - Based on the specific underlying pathophysiological cause.
General Pathophysiology of Manifestations:
- Manifestations stem directly from systemic tissue hypoxia and compensatory responses.
- Severity depends on the speed of onset, absolute severity of anemia, and presence of co-existing medical conditions.
- Hemoglobin (Hgb) levels serve as the primary metric to categorize clinical severity.
Integumentary Manifestations:
- Pallor: Reduced Hgb concentration and decreased cutaneous blood flow.
- Jaundice: Elevated concentration of serum bilirubin due to excess RBC breakdown.
- Pruritus: Increased serum and skin bile salt concentrations.
Cardiopulmonary Manifestations:
- Result from compensatory mechanisms by the heart and lungs to supply adequate $\text{O}_2$ to hypoxic tissues.
- Cardiac output is sustained by increasing both heart rate and stroke volume.

Nursing Assessment and Clinical Management

Comprehensive Nursing Assessment:
- Subjective Data:
  - Past medical history (PMH).
  - Current and past medication history.
  - Surgical history.
  - Detailed diet history.
- Objective Data:
  - Physical exam findings.
  - Laboratory diagnostics and blood panel trends.
General Nursing Interventions:
- Interventions are individualized based on patient needs and targeted at correcting the underlying cause:
  - Transfusion of blood or blood products.
  - Pharmacological administration (Erythropoietin, Vitamin Supplements).
  - Intravenous volume replacement therapy.
  - Dietary and lifestyle adjustments.
  - Supplemental oxygen ( $\text{O}_2$ ) therapy.
Gerontologic Considerations:
- Anemia is highly prevalent among older adult populations.
- Commonly linked to underlying chronic disease or nutritional deficiencies.
- Signs and symptoms are frequently unrecognized or misattributed to normal physiological aging changes.

Iron-Deficiency Anemia

Pathophysiology and Epidemiology:
- One of the most common chronic hematologic disorders worldwide.
- Iron is present in all RBCs as heme inside hemoglobin and as stored iron.
- Heme accounts for two-thirds ( $\frac{2}{3}$ ) of total body iron content.
Etiology:
- Inadequate dietary iron intake.
- Gastrointestinal malabsorption.
- Acute or chronic blood loss.
- Intravascular hemolysis.
- Pregnancy (due to increased maternal and fetal tissue demands).
Clinical Manifestations:
- General anemia signs and symptoms.
- Pallor: The single most common finding.
- Glossitis: Inflammation of the tongue (the second most common finding).
- Cheilitis: Inflammation of the lips.
Diagnostic Studies:
- Laboratory Values: Hgb, Hct, Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC), reticulocyte count, serum iron, Total Iron-Binding Capacity (TIBC), bilirubin, platelet count.
- Diagnostic Procedures: Stool guaiac test (occult blood), upper GI endoscopy, colonoscopy, bone marrow biopsy.
Drug Therapy:
- Oral Iron Supplements:
  - Inexpensive and convenient.
  - Total standard daily dose: $150\,\text{mg}$ to $200\,\text{mg}$ of elemental iron.
  - Best absorbed as ferrous sulfate in an acidic environment.
  - Enteric-coated or sustained-release preparations are counterproductive as they release iron past the optimal duodenal absorption site.
  - Liquid iron preparations must be diluted and ingested through a straw to prevent tooth staining.
  - Adverse side effects: Heartburn, constipation, diarrhea.
- Parenteral Iron Supplements:
  - Indications: Malabsorption, oral iron intolerance, requirement for iron exceeding oral intake limits, poor patient compliance.
  - Routes: Intramuscular (IM) or Intravenous (IV).
  - Note: IM administration carries a risk of staining the skin.
Collaborative Management and Patient Teaching:
- Goal: Treat the underlying disease causing reduced intake or malabsorption while replenishing iron stores.
- Interventions: Nutritional therapy, oral/parenteral supplements, packed RBC transfusions.
- At-risk groups: Premenopausal women, pregnant women, individuals from low socioeconomic backgrounds, older adults, patients experiencing active blood loss.
- Patient education: Dietary instruction, supplement administration instructions, review of diagnostic results, insistence on compliance.
- Iron therapy must continue for $2\,\text{months}$ to $3\,\text{months}$ after Hgb levels normalize to fully replenish iron storage reserves.

Megaloblastic Anemias

Pathophysiology:
- A group of disorders characterized by impaired cellular DNA synthesis leading to the production of enlarged RBC precursors termed megaloblasts.
- The vast majority result from a deficiency in Cobalamin (Vitamin $\text{B}_{12}$ ) or Folic Acid.
Cobalamin Deficiency:
- Role of Intrinsic Factor (IF):
  - Intrinsic factor is a protein secreted by parietal cells of the gastric mucosa.
  - IF is essential for cobalamin absorption in the distal ileum.
  - If IF is absent, cobalamin cannot be absorbed.
- Etiology:
  - Most common cause is Pernicious Anemia, caused by an absence of IF.
  - Pernicious anemia has an insidious onset, presenting predominantly in middle age or later, with higher prevalence in Scandinavian and African American populations.
  - Other causes: Gastric/GI surgery, chronic GI diseases, chronic alcoholism, long-term use of $\text{H}_2$ -histamine receptor blockers and proton pump inhibitors (PPIs), strict vegans/vegetarians.
- Clinical Manifestations:
  - General anemia symptoms develop slowly due to systemic tissue hypoxia.
  - Gastrointestinal: Sore tongue, anorexia, nausea, vomiting, abdominal pain.
  - Neuromuscular: Weakness, paresthesias of hands and feet, decreased vibratory and position sense, ataxia, muscle weakness, impaired cognitive/thought processes.
- Diagnostic Findings:
  - Macrocytic RBCs with abnormal morphology and fragile cell membranes.
  - Decreased serum cobalamin levels.
  - Normal serum folate levels alongside low cobalamin confirms cobalamin deficiency as the etiology.
  - Upper GI endoscopy with biopsy of gastric mucosa.
- Collaborative Care:
  - Parenteral (IM) or intranasal cobalamin administration is the treatment of choice.
  - Without treatment, patients will die within $1\,\text{year}$ to $3\,\text{years}$ .
  - Anemia is fully reversible with ongoing treatment, but long-standing neuromuscular deficits may be irreversible.
Folic Acid Deficiency:
- Pathophysiology: Folic acid is required for cellular DNA synthesis leading to RBC production.
- Etiology: Dietary deficiency, malabsorption syndromes, drugs interfering with absorption/metabolism (methotrexate, antiseizure drugs), chronic alcohol abuse, hemodialysis patients.
- Treatment: Early diagnostic detection and replacement therapy.

Anemia of Chronic Disease

Pathophysiology and Causes:
- Also known as Anemia of Inflammation.
- Etiologies: Chronic inflammation, autoimmune and infectious disorders (HIV, hepatitis, malaria), heart failure, malignant diseases, bleeding episodes.
- Pathophysiologic features: Underproduction of RBCs, mild shortening of RBC survival.
- RBC morphology: Normocytic, normochromic, and hypoproliferative.
- Typically presents as mild anemia, but can become severe if the underlying disorder is untreated.
Iron Metabolic Pathway Dynamics:
- Ingested Iron (Diet, Supplements) $\rightarrow$ Storage (Ferritin and Hemosiderin in bone marrow, liver, spleen, and macrophages) $\rightarrow$ Transport (Serum Transferrin) $\rightarrow$ RBC Incorporation (Hemoglobin) $\rightarrow$ Recycling (Macrophages in liver and spleen).
Diagnostic Profile:
- Elevated serum ferritin levels.
- Increased iron stores.
- Normal serum folate and cobalamin levels.
Management Strategies:
- Primary approach: Treating the underlying underlying inflammatory or systemic disorder.
- Blood transfusions are rarely indicated.
- Conservative, selective utilization of erythropoietin therapy.

Aplastic Anemia

Pathophysiology:
- Characterized by Pancytopenia—a severe reduction in all circulating blood cell types:
  - Red blood cells (RBCs).
  - White blood cells (WBCs).
  - Platelets.
- Accompanied by a hypocellular bone marrow.
- Severity ranges from chronic dysfunction to critical, acute emergency.
Etiology:
- Congenital: Primary chromosomal alterations.
- Acquired: Results from exposure to ionizing radiation, chemical agents, or viral and bacterial infections.
Clinical Manifestations:
- Development can be abrupt or gradual.
- Symptoms stem directly from suppression of bone marrow elements:
  - Erythroid Suppression: General anemia manifestations (fatigue, dyspnea, cardiovascular/cerebral hypoxia).
  - Leukocyte Suppression: Neutropenia and high susceptibility to infections.
  - Thrombocyte Suppression: Bleeding tendencies, prolonged bleeding time.
Diagnostic Findings:
- Low Hgb, low WBC count, low platelet count.
- Low reticulocyte count.
- Prolonged bleeding time.
- Elevated serum iron and TIBC.
- Hypocellular bone marrow with increased fat content (yellow marrow).
Prognosis and Collaborative Management:
- Prognosis for severe, untreated aplastic anemia is dismal.
- Median survival rate is $3\,\text{months}$ to $6\,\text{months}$ .
- Only $20\%$ of untreated patients survive longer than $1\,\text{year}$ .
- Treatment options: Immunosuppressive therapies and bone marrow transplantation can be curative.

Hemolytic Anemia

Pathophysiology:
- Characterized by premature destruction or hemolysis of RBCs at a rate exceeding bone marrow production capacity.
- Intrinsic Causes: Usually hereditary; results from intrinsic structural defects within the RBCs themselves.
- Extrinsic Causes: Acquired forms (more common); RBCs are structurally normal, but undergo damage caused by external environmental factors.
Clinical Manifestations:
- General systemic manifestations of anemia.
- Jaundice (due to elevated plasma bilirubin from RBC lysis).
- Hepatomegaly and Splenomegaly (enlargement of the liver and spleen due to cellular debris filtration hyperactivity).
Clinical Focus:
- Maintenance and protection of renal function is a primary focus of treatment to prevent acute kidney injury from hemoglobinuria.